GL1X · GenesisL1 explorer

MolNFT v1 · #162375 · protein

Structure of imp-13 metallo-beta-lactamase complexed with hydrolysed meropenem

6R73: “Structure of imp-13 metallo-beta-lactamase complexed with hydrolysed meropenem”. X-ray diffraction, 2 ligands (LMP, ZN), 3 pockets (best druggability 0.71). MolNFT v1 #162375 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
6R73
Type
protein
Length
432 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
EC
3.5.2.6
UniProt
Q7WYA8
Ligands
LMP, ZN
Pockets
3 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 28% helix, 31% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BBeta-lactamase (EC 3.5.2.6)protein21628% helix, 31% strandQ7WYA8

Ligands and binding sites

  • LMP · (2~{S},3~{R},4~{S})-2-[(2~{S},3~{R})-1,3-bis(oxidanyl)-1-oxidanylidene-butan-2-yl]-4-[(3~{S},5~{S})-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-3-methyl-3,4-dihydro-2~{H}-pyrrole-5-carboxylic acid · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13780.710.8250empty
21530.470.7723LMP, ZN
31430.450.7621LMP, ZN

Interfaces

1 interface between chains.

  • A–B · 712 Ų buried · 7 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 6R73 · Structure of IMP-13 metallo-beta-lactamase complexed with hydrolysed meropenem · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.